{
    "nctId": "NCT05871437",
    "briefTitle": "Huaier Granule on Reducing the Level of Tumor Markers in Patients With Early-stage Breast Cancer",
    "officialTitle": "Clinical Study of Huaier Granule on Reducing the Level of Tumor Markers in Patients With Early-stage Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Early-stage Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 379,
    "primaryOutcomeMeasure": "Recovery rate of any tumor marker (CEA/CA125/CA153) to normal",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 \u2264 age \u2264 75 years old, regardless of gender.\n* Postoperative pathological diagnosis of breast cancer.\n* Imaging or pathological examination without evidence of recurrence or metastasis.\n* If tumor markers are elevated, it is necessary to go to the corresponding department for medical treatment or issue a corresponding examination when necessary to exclude recurrence, metastasis or the second primary tumor of breast cancer.\n* One or more tumor markers in CEA/CA125/CA153 exceed the upper limit of normal values.\n* The liver and kidney functions meet the following conditions: AST and ALT\\< 3 ULN, total bilirubin \u2264 2 ULN, and blood creatinine\\<1.5 ULN;\n* Other laboratory tests meet the following requirements: Hb \u2265 9g/dl, platelet count \u2265 60 \u00d7 10\\^9/L, absolute neutrophil count\\>1.0 \u00d7 10\\^9/L.\n* The patient's ECOG physical state score is 0 or 1.\n* The subjects participated in this study voluntarily and signed an informed consent form.\n\nExclusion Criteria:\n\n* Diagnosed as any other malignant tumor within the 5 years prior to enrollment, except for malignant tumors with low risk of metastasis and death (5-year survival rate\\>90%), such as fully treated basal cell or squamous cell skin cancer or cervical cancer in situ.\n* Imaging or pathological confirmation of recurrence and metastasis.\n* Serious infections (CTCAE\\>Level 2) occurred within the first 4 weeks of enrollment, such as severe pneumonia, bacteremia, and infection complications that require hospitalization; Symptoms and signs of infection or the need for oral or intravenous antibiotic treatment within 2 weeks prior to enrollment, excluding the use of prophylactic antibiotics.\n* Suffering from severe acute and chronic diseases.\n* Suffering from severe diabetes whose blood sugar cannot be effectively controlled.\n* Patients who are unable to take oral medication, those who are allergic to the ingredients of Huaier granules, and pregnant or lactating women.\n* Drug abusers, or those who suffer from psychological or mental illnesses that may interfere with research compliance.\n* The researcher believes that it is not suitable to participate in this study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}